Sign In
Buy BNTX
$91.35
-0.90 (-0.98%)
At Close: Aug 04, 2026
BioNTech to Report Second Quarter 2022 Financial Results and Operational Update on August 8, 2022
06:45am, Monday, 25'th Jul 2022
Mainz, Germany, July 25, 2022 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the second quarter 2022 on Monday, August 8th
BioNTech and Pfizer in talks to delay Covid vaccine deliveries amid EU glut
07:36am, Tuesday, 19'th Jul 2022
BioNTech and Pfizer Inc (NYSE:PFE) are reportedly close to reaching an agreement with the European Union to extend Covid-19 vaccine deliveries until 2024, slowing deliveries amid a glut of shots in
Buy BioNTech Stock - Ride The New Wave Of Covid
01:10am, Tuesday, 19'th Jul 2022
Because of geopolitics, we have forgotten COVID, but in vain - the number of new cases is increasing, while the fall season has not even begun. As demand for vaccines picks up in the early fall, share
Does BioNTech SE Sponsored ADR (BNTX) Have the Potential to Rally 48% as Wall Street Analysts Expect?
11:35am, Tuesday, 12'th Jul 2022
The average of price targets set by Wall Street analysts indicates a potential upside of 47.9% in BioNTech SE Sponsored ADR (BNTX). While the effectiveness of this highly sought-after metric is questi
PFE, BNTX's COVID Jab Gets FDA's Full Nod for Adolescents
04:59pm, Monday, 11'th Jul 2022
Pfizer (PFE) and partner BioNTech's (BNTX) Comirnaty is the first COVID-19 vaccine to receive full approval in the United States for use in adolescents aged 12 years and older.
BioNTech sued by CureVac over its mRNA technology
09:46am, Wednesday, 06'th Jul 2022
CureVac (NASDAQ:CVAC) has filed a patent lawsuit in Germany against BioNTech (NASDAQ:BNTX) in what is one of the first court cases in which a company has sued another for using mRNA technology in d
CureVac Files COVID-19 Vaccine Patent Infringement Lawsuit Against BioNTech
09:36am, Tuesday, 05'th Jul 2022
CureVac N.V. (NASDAQ: CVAC) has moved to assert its intellectual property rights, accumulated over two decades of pioneering work in mRNA technology, which contributed to COVID-19 vaccine developmen
CureVac Sues BioNTech Over mRNA and Covid Vaccines. Pfizer Stock Isn't Spared.
07:46am, Tuesday, 05'th Jul 2022
CureVac says its intellectual property portfolio protects multiple inventions that are considered essential to Pfizer and BioNTech's Covid-19 vaccine.
BioNTech stock falls after CureVac files suit, saying COVID vaccine infringes patents
07:35am, Tuesday, 05'th Jul 2022
Shares of BioNTech SE BNTX, +5.63% fell 0.9% in premarket trading Tuesday, after CureVac N.V. CVAC, +4.63% filed in Germany a patent infringement suit against the biotechnology company.
FDA Recommends Adding New Omicron Subvariants to COVID Boosters
11:31am, Friday, 01'st Jul 2022
In anticipation of a new surge of COVID-19 infections later this year, the FDA recommends that COVID-19 vaccine manufacturers develop bivalent booster vaccines that contain the BA.4/BA.5 Omicron subva
Why BioNTech Stock Is Surging
02:53pm, Thursday, 30'th Jun 2022
BioNTech SE (NASDAQ: BNTX) shares are trading higher Thursday after the company and Pfizer Inc (NYSE: PFE) announced a new COVID-19 vaccine supply agreement with the U.S. government. Under terms of
This Analyst Says US Government Buying More COVID-19 Vaccines At Higher Prices
02:37pm, Thursday, 30'th Jun 2022
Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) announced a new COVID-19 vaccine supply agreement with the U.S. government. SVB Leerink says that the new contract implies the price per Com
Why BioNTech Stock Advanced Today
12:42pm, Thursday, 30'th Jun 2022
The U.S. government wants to buy more of its coronavirus vaccine.
U.S. to pay $3.2 billion to Pfizer, BioNTech for more COVID-19 vaccines for fall
05:03pm, Wednesday, 29'th Jun 2022
Pfizer Inc. PFE, +0.55% and BioNTech SE BNTX, +1.54% said late Wednesday they have inked a new agreement with the U.S. government to supply 105 million doses of their COVID-19 vaccines, including a fo
FDA recommends updating COVID booster shots to fight Omicron
11:25am, Wednesday, 29'th Jun 2022
Yahoo Finance's Anjalee Khemlani joins the Live show to discuss the FDA's vote to update its COVID-19 boosters.
